Skip to main content
. Author manuscript; available in PMC: 2018 Jun 13.
Published in final edited form as: Mol Pharm. 2018 Feb 2;15(3):1309–1318. doi: 10.1021/acs.molpharmaceut.7b01114

Table 1.

Sensitivity of Glioblastoma lines to chemotherapies. Concentration required to reduce cell viability by 50% (IC50) after 48 hour incubation with DXR or BCNU for glioblastoma cell lines U87-MG, LN-18, and LN-229, as measured by MTT assay.

Cell Line IC50 (μM)
DXR BCNU
U87-MG 0.13 380
LN-18 0.80 225
LN-229 1.10 280